These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 31011786)

  • 21. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Differential Ion Mobility Device Expands the Depth of Proteome Coverage and the Sensitivity of Multiplex Proteomic Measurements.
    Pfammatter S; Bonneil E; McManus FP; Prasad S; Bailey DJ; Belford M; Dunyach JJ; Thibault P
    Mol Cell Proteomics; 2018 Oct; 17(10):2051-2067. PubMed ID: 30007914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-field asymmetric waveform ion mobility spectrometry for mass spectrometry-based proteomics.
    Swearingen KE; Moritz RL
    Expert Rev Proteomics; 2012 Oct; 9(5):505-17. PubMed ID: 23194268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing the dynamic range and peak capacity of nanoflow LC-FAIMS-MS on an ion trap mass spectrometer for proteomics.
    Canterbury JD; Yi X; Hoopmann MR; MacCoss MJ
    Anal Chem; 2008 Sep; 80(18):6888-97. PubMed ID: 18693747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Throughput Analyses of Therapeutic Antibodies Using High-Field Asymmetric Waveform Ion Mobility Spectrometry Combined with SampleStream and Intact Protein Mass Spectrometry.
    Shi RL; Dillon MA; Compton PD; Sawyer WS; Thorup JR; Kwong M; Chan P; Chiu CPC; Li R; Yadav R; Lee GY; Gober JG; Li Z; ElSohly AM; Ovacik AM; Koerber JT; Spiess C; Josephs JL; Tran JC
    Anal Chem; 2023 Nov; 95(47):17263-17272. PubMed ID: 37956201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Separation of Structurally Similar Anabolic Steroids as Cation Adducts in FAIMS-MS.
    Wei MS; Kemperman RHJ; Palumbo MA; Yost RA
    J Am Soc Mass Spectrom; 2020 Feb; 31(2):355-365. PubMed ID: 32031405
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of paralytic shellfish toxins using high-field asymmetric waveform ion mobility spectrometry with liquid chromatography-mass spectrometry.
    Beach DG; Melanson JE; Purves RW
    Anal Bioanal Chem; 2015 Mar; 407(9):2473-84. PubMed ID: 25619987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insights and prospects for ion mobility-mass spectrometry in clinical chemistry.
    Koomen DC; May JC; McLean JA
    Expert Rev Proteomics; 2022 Jan; 19(1):17-31. PubMed ID: 34986717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-field asymmetric waveform ion mobility spectrometry coupled with liquid chromatography/electrospray ionization tandem mass spectrometry (LC/ESI-FAIMS-MS/MS) multi-component bioanalytical method development, performance evaluation and demonstration of the constancy of the compensation voltage with change of mobile phase composition or flow rate.
    Wu ST; Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2007; 21(22):3667-76. PubMed ID: 17939154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced MS/MS coverage for metabolite identification in LC-MS-based untargeted metabolomics by target-directed data dependent acquisition with time-staggered precursor ion list.
    Wang Y; Feng R; Wang R; Yang F; Li P; Wan JB
    Anal Chim Acta; 2017 Nov; 992():67-75. PubMed ID: 29054151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of a rapid profiling method for the analysis of polar analytes in urine using HILIC-MS and ion mobility enabled HILIC-MS.
    King AM; Mullin LG; Wilson ID; Coen M; Rainville PD; Plumb RS; Gethings LA; Maker G; Trengove R
    Metabolomics; 2019 Jan; 15(2):17. PubMed ID: 30830424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidimensional separation and analysis of alpha-1-acid glycoprotein N-glycopeptides using high-field asymmetric waveform ion mobility spectrometry (FAIMS) and nano-liquid chromatography tandem mass spectrometry.
    Chandler KB; Marrero Roche DE; Sackstein R
    Anal Bioanal Chem; 2023 Jan; 415(3):379-390. PubMed ID: 36401639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolomics: Going Deeper, Going Broader, Going Further.
    Moco S; Buescher JM
    Methods Mol Biol; 2023; 2554():155-178. PubMed ID: 36178626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ultra-Performance Liquid Chromatography-Ion Mobility Separation-Quadruple Time-of-Flight MS (UHPLC-IMS-QTOF MS) Metabolomics for Short-Term Biomarker Discovery of Orange Intake: A Randomized, Controlled Crossover Study.
    Lacalle-Bergeron L; Portolés T; López FJ; Sancho JV; Ortega-Azorín C; Asensio EM; Coltell O; Corella D
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32610451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Trapping-Micro-LC-FAIMS/dCV-MS Strategy for Ultrasensitive and Robust Targeted Quantification of Protein Drugs and Biomarkers.
    Shen Q; Pu J; Xue C; Zhang M; Qu Y; Huo S; Belford M; Maxey C; Wijeratne N; Martins C; Peterman S; Qian WJ; Boeser C; Qu J
    Anal Chem; 2024 Aug; 96(32):13140-13149. PubMed ID: 39078725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adding a new separation dimension to MS and LC-MS: What is the utility of ion mobility spectrometry?
    D'Atri V; Causon T; Hernandez-Alba O; Mutabazi A; Veuthey JL; Cianferani S; Guillarme D
    J Sep Sci; 2018 Jan; 41(1):20-67. PubMed ID: 29024509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Untargeted Lipidomics Workflow Incorporating High-Resolution Demultiplexing (HRdm) Drift Tube Ion Mobility-Mass Spectrometry.
    Koomen DC; May JC; Mansueto AJ; Graham TR; McLean JA
    J Am Soc Mass Spectrom; 2024 Oct; 35(10):2448-2457. PubMed ID: 39276100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of mass spectrometry performance for proteomic analyses using high-field asymmetric waveform ion mobility spectrometry (FAIMS).
    Bonneil E; Pfammatter S; Thibault P
    J Mass Spectrom; 2015 Nov; 50(11):1181-95. PubMed ID: 26505763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid Extraction Surface Analysis (LESA) High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) Mass Spectrometry for In Situ Analysis of Intact Proteins.
    Griffiths RL; Kocurek KI; Cooper HJ
    Methods Mol Biol; 2020; 2084():191-201. PubMed ID: 31729662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.